These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16547230)

  • 1. Downstream of tyrosine kinases-1 and Src homology 2-containing inositol 5'-phosphatase are required for regulation of CD4+CD25+ T cell development.
    Kashiwada M; Cattoretti G; McKeag L; Rouse T; Showalter BM; Al-Alem U; Niki M; Pandolfi PP; Field EH; Rothman PB
    J Immunol; 2006 Apr; 176(7):3958-65. PubMed ID: 16547230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling.
    Ott VL; Tamir I; Niki M; Pandolfi PP; Cambier JC
    J Immunol; 2002 May; 168(9):4430-9. PubMed ID: 11970986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the Jun N-terminal protein kinase pathway by SHIP-1, a lipid phosphatase that interacts with the adaptor molecule Dok-3.
    Robson JD; Davidson D; Veillette A
    Mol Cell Biol; 2004 Mar; 24(6):2332-43. PubMed ID: 14993273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling.
    Waterman PM; Marschner S; Brandl E; Cambier JC
    Immunol Lett; 2012 Mar; 143(1):122-30. PubMed ID: 22370159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2.
    Dong S; Corre B; Foulon E; Dufour E; Veillette A; Acuto O; Michel F
    J Exp Med; 2006 Oct; 203(11):2509-18. PubMed ID: 17043143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of integrin alphaIIbbeta3 outside-in signaling reveals Src-kinase-independent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions.
    Senis YA; Antrobus R; Severin S; Parguiña AF; Rosa I; Zitzmann N; Watson SP; García A
    J Thromb Haemost; 2009 Oct; 7(10):1718-26. PubMed ID: 19682241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes.
    Kepley CL; Taghavi S; Mackay G; Zhu D; Morel PA; Zhang K; Ryan JJ; Satin LS; Zhang M; Pandolfi PP; Saxon A
    J Biol Chem; 2004 Aug; 279(34):35139-49. PubMed ID: 15151996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dok-1 and Dok-2 Are Required To Maintain Herpes Simplex Virus 1-Specific CD8
    Lahmidi S; Yousefi M; Dridi S; Duplay P; Pearson A
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Dok-1 and Dok-2 in mice causes severe experimental colitis accompanied by reduced expression of IL-17A and IL-22.
    Waseda M; Arimura S; Shimura E; Nakae S; Yamanashi Y
    Biochem Biophys Res Commun; 2016 Sep; 478(1):135-142. PubMed ID: 27450811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy.
    O'Neill SK; Getahun A; Gauld SB; Merrell KT; Tamir I; Smith MJ; Dal Porto JM; Li QZ; Cambier JC
    Immunity; 2011 Nov; 35(5):746-56. PubMed ID: 22078222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilevel control of B-cell activation by the inositol 5-phosphatase SHIP.
    Brauweiler AM; Tamir I; Cambier JC
    Immunol Rev; 2000 Aug; 176():69-74. PubMed ID: 11043768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the Timing of Action of the PAG Adaptor Using Quantitative Proteomics Analysis of Primary T Cells.
    Reginald K; Chaoui K; Roncagalli R; Beau M; Goncalves Menoita M; Monsarrat B; Burlet-Schiltz O; Malissen M; Gonzalez de Peredo A; Malissen B
    J Immunol; 2015 Dec; 195(11):5472-81. PubMed ID: 26512138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHIP limits immunoregulatory capacity in the T-cell compartment.
    Collazo MM; Wood D; Paraiso KH; Lund E; Engelman RW; Le CT; Stauch D; Kotsch K; Kerr WG
    Blood; 2009 Mar; 113(13):2934-44. PubMed ID: 19136659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dok-1 and Dok-2 Regulate the Formation of Memory CD8+ T Cells.
    Laroche-Lefebvre C; Yousefi M; Daudelin JF; Charpentier T; Tarrab E; Klinck R; Lamarre A; Labrecque N; Stäger S; Duplay P
    J Immunol; 2016 Nov; 197(9):3618-3627. PubMed ID: 27664281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dok-1 is a positive regulator of IL-4 signalling and IgE response.
    Inoue A; Yasuda T; Yamamoto T; Yamanashi Y
    J Biochem; 2007 Aug; 142(2):257-63. PubMed ID: 17827176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dok-1 and Dok-2 are negative regulators of T cell receptor signaling.
    Yasuda T; Bundo K; Hino A; Honda K; Inoue A; Shirakata M; Osawa M; Tamura T; Nariuchi H; Oda H; Yamamoto T; Yamanashi Y
    Int Immunol; 2007 Apr; 19(4):487-95. PubMed ID: 17329234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dok1 and SHIP act as negative regulators of v-Abl-induced pre-B cell transformation, proliferation and Ras/Erk activation.
    Oki S; Limnander A; Yao PM; Niki M; Pandolfi PP; Rothman PB
    Cell Cycle; 2005 Feb; 4(2):310-4. PubMed ID: 15655368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinase.
    Gérard A; Favre C; Garçon F; Némorin JG; Duplay P; Pastor S; Collette Y; Olive D; Nunès JA
    Oncogene; 2004 Feb; 23(8):1594-8. PubMed ID: 14647425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Dok-1 and Dok-2 in leukemia suppression.
    Niki M; Di Cristofano A; Zhao M; Honda H; Hirai H; Van Aelst L; Cordon-Cardo C; Pandolfi PP
    J Exp Med; 2004 Dec; 200(12):1689-95. PubMed ID: 15611295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.